Class information for:
Level 1: PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9138 1117 48.8 93%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
935 10411 PPAR GAMMA//PIOGLITAZONE//ROSIGLITAZONE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PPAR GAMMA Author keyword 24 10% 20% 225
2 PPAR RESEARCH Journal 14 17% 7% 75
3 TROGLITAZONE Author keyword 11 14% 6% 70
4 CIGLITAZONE Author keyword 9 34% 2% 21
5 EFATUTAZONE Author keyword 6 80% 0% 4
6 ALPHA ARYLOXY ALPHA METHYLHYDROCINNAMIC ACID DERIVATIVE Author keyword 6 100% 0% 4
7 BIOMED MOL SCI PHARMACOL TOXICOL Address 4 75% 0% 3
8 TZD18 Author keyword 3 100% 0% 3
9 PPAR GAMMA LIGANDS Author keyword 3 33% 1% 7
10 15D PGJ2 Author keyword 2 14% 1% 16

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PPAR GAMMA 24 10% 20% 225 Search PPAR+GAMMA Search PPAR+GAMMA
2 TROGLITAZONE 11 14% 6% 70 Search TROGLITAZONE Search TROGLITAZONE
3 CIGLITAZONE 9 34% 2% 21 Search CIGLITAZONE Search CIGLITAZONE
4 EFATUTAZONE 6 80% 0% 4 Search EFATUTAZONE Search EFATUTAZONE
5 ALPHA ARYLOXY ALPHA METHYLHYDROCINNAMIC ACID DERIVATIVE 6 100% 0% 4 Search ALPHA+ARYLOXY+ALPHA+METHYLHYDROCINNAMIC+ACID+DERIVATIVE Search ALPHA+ARYLOXY+ALPHA+METHYLHYDROCINNAMIC+ACID+DERIVATIVE
6 TZD18 3 100% 0% 3 Search TZD18 Search TZD18
7 PPAR GAMMA LIGANDS 3 33% 1% 7 Search PPAR+GAMMA+LIGANDS Search PPAR+GAMMA+LIGANDS
8 15D PGJ2 2 14% 1% 16 Search 15D+PGJ2 Search 15D+PGJ2
9 15 DEOXY DELTA1214 PROSTAGLANDIN J2 2 67% 0% 2 Search 15+DEOXY+DELTA1214+PROSTAGLANDIN+J2 Search 15+DEOXY+DELTA1214+PROSTAGLANDIN+J2
10 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GAMMA 2 67% 0% 2 Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+GAMMA+GAMMA Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+GAMMA+GAMMA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LIGAND TROGLITAZONE 46 82% 2% 27
2 C57BL 6J APCMIN MICE 18 89% 1% 8
3 15 DEOXY DELTA12 14 PROSTAGLANDIN J2 11 12% 8% 89
4 INHIBIT GROWTH 11 28% 3% 34
5 INTESTINAL POLYP FORMATION 9 43% 2% 17
6 GAMMA LIGAND TROGLITAZONE 8 100% 0% 5
7 DMBA INDUCED MAMMARY 7 67% 1% 6
8 J2 3 13% 2% 20
9 LIGANDS SUPPRESS 3 60% 0% 3
10 GAMMA INDEPENDENT MECHANISMS 2 67% 0% 2

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PPAR RESEARCH 14 17% 7% 75

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists 2004 287 78 71%
A new dawn for the use of thiazolidinediones in cancer therapy 2014 4 45 64%
PPAR gamma-independent antitumor effects of thiazolidinediones 2009 52 38 68%
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? 2007 67 63 78%
Biology of PPAR gamma in cancer: A critical review on existing lacunae 2007 52 80 83%
Peroxisome-proliferator-activated receptors and cancers: Complex stories 2004 312 131 35%
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities 2011 20 136 55%
Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs 2010 18 53 66%
PPAR gamma and Apoptosis in Cancer 2008 26 78 63%
Peroxisome proliferator-activated receptor gamma in malignant diseases 2006 82 137 52%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOMED MOL SCI PHARMACOL TOXICOL 4 75% 0.3% 3
2 LYMPHOMA BIOL PROGRAM 1 31% 0.4% 4
3 MRC I EM TISSUE REGENERAT 1 18% 0.6% 7
4 EA SIGNALISAT GENOM RECH TRANSLAT ONCOL SIGRETO 1 100% 0.2% 2
5 CLIN MALAD PAREIL DIGESTIF 1 33% 0.2% 2
6 U834 1 33% 0.2% 2
7 BIOCHIM EQUIPE MIXTE 1 50% 0.1% 1
8 BIOMED GENOM BIOINFORMAT 1 50% 0.1% 1
9 CANC BIOL CELL BIOL 1 50% 0.1% 1
10 CLIN STEM CELL LIAONING PROVAFFILIATED HOSP 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000276139 15D PGJ2//15 DEOXY DELTA12 14 PROSTAGLANDIN J2//PPAR RESEARCH
2 0.0000218706 PPAR DELTA//PPAR BETA DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA
3 0.0000192343 PRO12ALA POLYMORPHISM//PRO12ALA//PPAR GAMMA 2
4 0.0000128216 CYCLOPENTENONE PROSTAGLANDINS//DELTA12 PROSTAGLANDIN J2//DELTA 12 PROSTAGLANDIN J2
5 0.0000112039 TROGLITAZONE//JTT 501//CAS 97322 87 7
6 0.0000084186 PIOGLITAZONE//ROSIGLITAZONE//THIAZOLIDINEDIONES
7 0.0000081902 9 CIS UAB30//NSC23925//TARGRETIN
8 0.0000063831 PEROXISOME PROLIFERATORS//PEROXISOME PROLIFERATOR//3 THIA FATTY ACIDS
9 0.0000053181 METFORMIN//ANTIDIABETIC BIGUANIDES//GLARGINE
10 0.0000052734 CDKN3//CYCLIN DEPENDENT KINASE ASSOCIATED PROTEIN PHOSPHATASE//CYTOKINE EXPRESSION PATTERN